Literature DB >> 3068314

Biological activities of human granulocyte-macrophage colony-stimulating factor.

S C Clark1.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) has emerged as an important regulation for hematopoietic cell development and function. Within the myeloid lineages, GM-CSF serves as a growth and developmental factor for intermediate-stage progenitors between early, interleukin 3-responsive and late granulocyte colony-stimulating factor-responsive precursors. GM-CSF also serves as an activator of circulating effector cells. The ability of GM-CSF to induce monocyte expression of tumor necrosis factor, interleukin 1 and other factors, further ties this hormone into a network of cytokines that interact to regulate many hematologic and immunologic responses. The availability of large quantities of recombinant GM-CSF now provides the opportunity and challenge not only for unraveling the mechanisms regulating hematopoiesis, but also for developing new therapies for enhancement of host defense against infection that were not previously possible.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3068314     DOI: 10.1002/stem.5530060602

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  3 in total

1.  Correction of neutropenia associated with chronic lymphocytic leukaemia following treatment with granulocyte-macrophage colony-stimulating factor.

Authors:  A A Hollander; H C Kluin-Nelemans; H R Haak; A C Stern; R Willemze; W E Fibbe
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

2.  The potential role of recombinant hematopoietic colony-stimulating factors in preventing infections in the immunocompromised host.

Authors:  J Rusthoven
Journal:  Can J Infect Dis       Date:  1991

3.  Identification of a functional receptor for granulocyte colony-stimulating factor on platelets.

Authors:  K Shimoda; S Okamura; N Harada; S Kondo; T Okamura; Y Niho
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.